98%
921
2 minutes
20
Background: The aim of the current study was to identify predictors of erectile dysfunction (ED) and obstructive sleep apnea syndrome (OSAS) in male participants at Italian web-survey.
Methods: A cross-sectional web-based survey was administered via Google Forms between July 17 and October 31, 2022, among Italian participants. The erectile function and the excessive daytime sleepiness were measured through the International Index of Erectile Function - 5 (IIEF5) and Epworth Sleepiness Scale (ESS), respectively. Two separate and independent multivariable logistic regression models (mLRMs) were fitted to predict ED and OSAS, respectively, in men answering to the survey.
Results: A total of 238 patients were identified. Of those, 58 (24%) reported to be affected by OSAS disease. Higher proportion of mild (21 vs. 6%), mild-to-moderate (9 vs. 5%), and severe (16 vs. 7%) ED were recorded in OSAS vs. non-OSAS patients (P<0.001). In mLRMs predicting ED (IIEF5≤7), age (OR: 1.04, 95% confidence interval [CI]: 1.01-1.06; P=0.002), and IPSS total score (OR:1.08, 95% CI: 1.02-1.15; P=0.006) were independent predictors. In mLRMs predicting OSAS, age (OR: 1.08, 95% CI: 1.05-1.12; P<0.001), Body Mass Index (BMI; OR: 1.12, 95% CI: 1.05-1.21; P<0.001), and ESS score (OR:1.14, 95% CI: 1.05-1.24; P=0.001) were independent predictors. In the subgroup analyses predicting severe ED, ESS and age or BMI or IPSS resulted as independent predictors (OR from 0.7 to 0.8; all P<0.05).
Conclusions: The ESS score independently predicted severe ED in males. As a result, the OSAS disease should be explored in patients who harbored severe ED to address those patients for a prompt ear, nose and throat evaluation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.23736/S2724-6051.24.05925-1 | DOI Listing |
Fr J Urol
September 2025
Department of urology, Maison de Santé Protestante de Bordeaux-Bagatelle, Talence, France; Department of urology, HIA Robert-Picqué, Villenave d'Ornon, France.
Objectives: To evaluate the efficacy and safety of oral phosphodiesterase-5 inhibitors (PDE5Is) in the treatment of erectile dysfunction (ED). Additionally, to compare various PDE5Is and assess their suitability for different patient populations.
Evidence Acquisition: A systematic review of literature published from January 1999 to January 2023 was conducted following the PICOS criteria.
Urol J
September 2025
Isfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Purpose: Men with lower urinary tract symptoms (LUTS) from benign prostatic hyperplasia (BPH) often experience erectile dysfunction (ED). While transurethral resection of the prostate (TURP) can improve ED, new-onset ED remains a concern. This study compares monopolar (M-TURP) and bipolar (B-TURP) techniques, with a subgroup analysis based on phosphodiesterase-5 inhibitor (PDE5i) use.
View Article and Find Full Text PDFAnn Vasc Surg
September 2025
CETI, 8 rue de Duras, 75008 Paris, France.
Objective: Assess results of simultaneous ligation and embolization for caverno-venous leakage (CVL) in patients with erectile dysfunction (ED) resistant to 5-Phosphodiesterase inhibitors.
Patients And Methods: Data from consecutive patients with ED operated-on for CVL, were collected prospectively. CVLs were diagnosed by Pharmacologicaly-Challenged Penile Duplex Sonography (PC-PDS) and computed tomography cavernosography.
Endoscopy
December 2025
Department of Gastroenterology and Endoscopy, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France.
J Int Med Res
September 2025
Woman and Child Health Department, College of Medicine, Taibah University, Saudi Arabia.
ObjectiveThis study aimed to assess the prevalence and associated factors of male sexual dysfunction in a population of young men using validated tools to evaluate erectile function and its contributing factors.MethodsA community-based cross-sectional study was conducted between April 2023 and August 2024 among married men aged ≤40 years in Saudi Arabia. Participants were randomly selected from public gatherings across five regions and interviewed using the International Index of Erectile Function and Sexual Health Inventory for Men.
View Article and Find Full Text PDF